FDA.reportPublic FDA data

FLULAVAL 2025-2026 vaccine 0.5 ML Prefilled Syringe

RxCUI
2718462
RxNorm name
FLULAVAL 2025-2026 vaccine 0.5 ML Prefilled Syringe
Display name
FLULAVAL 2025-2026 vaccine 0.5 ML Prefilled Syringe
Full name
FLULAVAL 2025-2026 vaccine 0.5 ML Prefilled Syringe
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:24

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125163Flulaval, Flulaval QuadrivalentInfluenza Vaccine351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
dccfb747-8f64-46ec-3993-95195b585581FLULAVAL 2025-2026 vaccine 0.5 ML Prefilled SyringePSN15These highlights do not include all the information needed to use FLULAVAL safely and effectively. See full prescribing information for FLULAVAL. FLULAVAL (Influenza Vaccine) Injectable Suspension, for Intramuscular Use 2025-2026 Formula Initial U.S. Approval: 200620260306
dccfb747-8f64-46ec-3993-95195b585581Flulaval 2025-2026 vaccine 0.5 ML Prefilled SyringeSY15These highlights do not include all the information needed to use FLULAVAL safely and effectively. See full prescribing information for FLULAVAL. FLULAVAL (Influenza Vaccine) Injectable Suspension, for Intramuscular Use 2025-2026 Formula Initial U.S. Approval: 200620260306
dccfb747-8f64-46ec-3993-95195b5855810.5 ML influenza A virus A/Croatia/10136RV/2023 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/4897/2022 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML Prefilled Syringe [Flulaval 2025-2026]SBD15These highlights do not include all the information needed to use FLULAVAL safely and effectively. See full prescribing information for FLULAVAL. FLULAVAL (Influenza Vaccine) Injectable Suspension, for Intramuscular Use 2025-2026 Formula Initial U.S. Approval: 200620260306